StockData

Acro Biomedical Co., Ltd. (ACBM) stock

ACBMOTCServices-Amusement & Recreation ServicesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 4/30
$0.03+0.00 (0.00%)

Close on Oct 19, 2026Market cap $1.56MP/E –Yield –

Acro Biomedical price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Acro Biomedical's price to sales ratio was 17.5× on Jan 31, 2024, against 261.2× a year earlier. Over the last 5 years it ranged from 17.5× to 425.3×, with a median of 158.7×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Jan 31, 202417.5×+0.0
2023Dec 29, 202317.5×−283.9
2022Dec 30, 2022301.4×+95.2
2021Dec 31, 2021206.2×+103.9
2020Dec 31, 2020102.3×−26.1
2019Dec 31, 2019128.4×+105.4
2018Dec 31, 201822.9×–

More Acro Biomedical figures

See a number that looks wrong?